Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/27/2025

Cefuroxime Treatment for Complicated Urinary Tract Infections

Introduction to Cefuroxime Therapy

  • The culture result showing susceptibility to cefuroxime is the definitive guide for continuing therapy, as stated by the Praxis Medical Insights guideline 1

Treatment Duration and Follow-up

  • Continue cefuroxime 500 mg orally twice daily for 10-14 days for complicated UTIs, as recommended by the Praxis Medical Insights guideline 1
  • Obtain follow-up urine culture after completion of therapy to ensure resolution of infection, as suggested by the Praxis Medical Insights guideline 1

Antibiotic Selection and Management

  • The European Association of Urology emphasizes that antimicrobial susceptibility testing serves as the definitive guide for clinicians in selecting appropriate antimicrobial agents 2
  • Always base treatment decisions on the specific antibiotic susceptibility results, not on related but different antibiotics, according to the Praxis Medical Insights guideline 1

Considerations for Clinical Improvement

  • If clinical improvement is not evident within 72 hours, reevaluate and consider imaging to rule out complications such as obstruction or abscess formation, as recommended by the Praxis Medical Insights guidelines 1, 3

Efficacy of Cefuroxime

  • While cefuroxime is appropriate based on susceptibility, oral β-lactam agents (including cephalosporins) generally achieve lower efficacy rates than fluoroquinolones for complicated UTIs, as noted by the Praxis Medical Insights guidelines 3, 4

REFERENCES

1

Complicated Urinary Tract Infections Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3

Complicated Urinary Tract Infections with Non-Obstructing Nephrolithiasis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Empiric Antibiotic Therapy for Complicated UTIs in Patients with Type 2 DM and CKD Stage 2 [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025